Wang, Jiang-Hui https://orcid.org/0000-0002-1551-9660
Gessler, Dominic J. https://orcid.org/0000-0003-0067-7444
Zhan, Wei
Gallagher, Thomas L.
Gao, Guangping
Article History
Received: 5 July 2023
Revised: 8 February 2024
Accepted: 19 February 2024
First Online: 3 April 2024
Competing interests
: G.G. is a scientific co-founder of Voyager Therapeutics, Adrenas Therapeutics, and Aspa Therapeutics, and holds equity in these companies. G.G. is an inventor on patents with potential royalties licensed to Voyager Therapeutics, Aspa Therapeutics, and other biopharmaceutical companies. D.J. G. is a cofounder of Aspa Therapeutics and holds equity in the company. D.J.G. is an inventor of patents with potential royalties licensed to Aspa Therapeutics and other biopharmaceutical companies. The remaining authors declare no competing interests. G.G. is one of the Associate Editors of <i>Signal Transduction and Targeted Therapy</i>, but he was not involved in the editorial administration and review of the manuscript.